Patients with good collateralization may profit from cilostazol

Cardiology. 2012;123(3):142; author reply 143-4. doi: 10.1159/000342276. Epub 2012 Oct 24.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Coronary Restenosis / prevention & control*
  • Female
  • Humans
  • Male
  • Percutaneous Coronary Intervention / methods*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Stents*
  • Tetrazoles / therapeutic use*

Substances

  • Platelet Aggregation Inhibitors
  • Tetrazoles